Saxagliptin (Compound)

Synonyms:Saxagliptin, Onglyza, 361442-04-8, BMS-477118, BMS 477118, OPC-262, UNII-8I7IO46IVQ, 8I7IO46IVQ, CHEMBL385517, CHEBI:71272, BMS-477118-11, BMS477118, (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile, (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, (1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile, (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, (1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, Saxagliptin [INN], Saxagliptine, Saxagliptin (BMS-477118,Onglyza), HSDB 8199, OPC 262, NCGC00242597-01, Saxagliptin anhydrous, 1073057-20-1, Saxagliptin (USAN/INN), DSSTox_CID_28506, DSSTox_RID_82778, DSSTox_GSID_48580, SCHEMBL17168, MLS006011223, GTPL6316, Saxagliptin - BMS-477118, DTXSID7048580, SCHEMBL20243458, BDBM11542, HMS3264P11, Pharmakon1600-01502500, Tox21_112908, BDBM50225074, NSC760407, s1540, AKOS015896547, AC-6008, CCG-213084, CCG-267647, CS-0650, DB06335, EX-7795, NSC-760407, NCGC00242597-02, NCGC00242597-10, 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-, HY-10285, SMR004702984, AM20090693, CAS-361442-04-8, D08996, AB01562984_01, AB01562984_02, Q3121121, BRD-A81513827-001-03-6, Z2235802036, (S)-3-Hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile TFA salt, (1S,6S)-2-(2-adamantan-1-yl-2-amino-acetyl)-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile, (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2,2,2-trifluoroacetic acid, (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-oxoethyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, (1S,3S,5S)-2-[(S)-2-amino-2-(3-hydroxy-adamantan-1-yl)-acetyl]-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile, 2-Azabicyclo(3.1.0)hexane-3-carbonitrile, 2-((2S)-amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl) , (1S,3S,5S)-, 2-Azabicyclo[3.1.0]hexane-3-carbonitrile,2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-
Pubchem:PUBCHEM:11243969
Id:d9aebe35-bd5c-5e97-9b61-e1f7831feff4
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Saxagliptin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Saxagliptin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Saxagliptin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.